γδ TCR-T Cell Discovery Service

Online Inquiry

Creative Biolabs, as a pioneering service provider in the domain of antibody discovery and immunotherapy, boasts extensive expertise garnered over the years. We are excited to introduce our cutting-edge platform tailored to offer a γδ T cell receptor (TCR) T cell discovery service with therapeutic applications. This technology empowers patients to harness their T-cells to combat and eliminate tumor cells and infected cells.

Features of γδ TCR

Gamma delta (γδ) T cells represent a unique subset of T lymphocytes that differ from the more common αβ T cells in terms of their T cell receptor (TCR) structure. This structural difference endows γδ T cells with distinctive properties and functions.

Within the spectrum of TCRs, there exist two main types: αβ TCR and γδ TCR. γδ TCR-T cells typically constitute a small proportion of peripheral blood lymphocytes, they play a crucial role in human immune defense. When the physiological state undergoes changes, γδ T cells can effectively migrate and eliminate tumor cells without relying on antigen-presenting cell activation or lymphoid system cloning and expansion. This, in turn, triggers normal antigen presentation in the lymphoid system and activates a systemic immune response. The crux of γδ TCR's cancer cell recognition lies in identifying unique signal molecules expressed on their surface.

Fig.1 Enhance γδ T Cell Anti-Tumor Activity.¹

Our γδ TCR-T Cell Discovery Service

High-Throughput Screening
Our service begins with high-throughput screening, where we leverage cutting-edge techniques to identify γδ TCRs with exceptional antigen specificity. This process allows us to select the most promising candidates for further development.
TCR Engineering and Optimization
Once potential γδ TCR candidates are identified, our expert team of scientists employs advanced genetic engineering techniques to optimize their binding affinity and specificity. This fine-tuning ensures that the γδ TCR-T cells exhibit enhanced therapeutic potential.

We provide expert, cutting-edge services to clients worldwide, guiding them towards successful project completion. It is our commitment to advance your projects and expedite progress toward clinical trials through the utilization of our advanced technologies, platforms, and resources. For more information, please don't hesitate to reach out to us, and we will respond promptly.

Reference

Guranda Chitadze, et al. (2017). Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses. Trends in immunology. 38(9), 668-678.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates

NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER

NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION

Novel Solution. (Creative Biolabs Authorized)

NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY

New Technology. (Creative Biolabs Authorized)

NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION